Table 1 Logistic regression of MVI presence based on preoperative data in the training cohort
Variable | Univariate logistic OR (95% CI) | Regression P | Multivariate logistic OR (95% CI) | Regression P |
|---|---|---|---|---|
Sex, male vs female | 0.55 (0.13–2.42) | 0.43 |  |  |
Age, year | 0.99 (0.94–1.03) | 0.55 |  |  |
Tumor number | 0.82 (0.23–2.91) | 0.76 |  |  |
Tumor diameter, cm | 1.26 (1.03–1.55) | 0.02 | 1.197 (0.924–1.552) | 0.17 |
Capsule invasion, Complete vs incomplete | 2.27 (0.86–6.03) | 0.1 |  |  |
WBCs, 109/L | ||||
  < 4 vs 4–10 | 0.83 (0.09–7.68) | 0.87 |  |  |
 4–10 vs > 10 | 0.49 (0.08–3.21) | 0.46 |  |  |
HGB, g/L | ||||
  < 120 vs 120–160 | 1 (0.07–14.64) | 1 |  |  |
 120–160 vs > 160 | 1.93 (0.52–7.18) | 0.33 |  |  |
NEUT, 109/L | ||||
  < 2.04 vs 2.04–7.50 | 1 (0.12–8.31) | 1 |  |  |
 2.04–7.50 vs > 7.50 | 0.8 (0.15–4.33) | 0.8 |  |  |
MONO, 0.12–0.8 vs > 0.8 × 109/L | 0.83 (0.11–6.25) | 0.86 |  |  |
LYMPH, < 0.80 vs 0.80–0.40 × 109/L | 2.65 (0.26–26.82) | 0.41 |  |  |
PLT, 109/L | ||||
  < 100 vs 100–300 | 18781632.9 (0–Inf) | 0.99 |  |  |
 100–300 vs > 300 | 13042800.6 (0–Inf) | 0.99 |  |  |
PT(s), 10.0–13.2 vs > 13.2 S | 1.15 (0.35–3.76) | 0.82 |  |  |
APTT, S | ||||
  < 20.9 vs 20.9–34.6 | 1.33 (0.07–26.62) | 0.85 |  |  |
 20.9–34.6 vs > 34.6 | 1.75 (0.15–20.35) | 0.65 |  |  |
D-D, ≤ 0.55 vs > 0.55 mg/L FEU | 0.42 (0.14–1.28) | 0.13 |  |  |
GLU, mmol/L | ||||
  < 3.89 vs 3.89–6.38 | 0 (0–Inf) | 0.99 |  |  |
 3.89–6.38 vs > 6.38 | 1.26 (0.43–3.7) | 0.67 |  |  |
CRE, µmol/L | ||||
  < 57.0 vs 57.0–97.0 | 1.67 (0.19–14.27) | 0.64 |  |  |
 57.0–97.0 vs > 97.0 | 1.44 (0.31–6.62) | 0.64 |  |  |
ALB, < 40.0 vs 40.0–55.0 g/L | 0.79 (0.27–2.31) | 0.66 |  |  |
ALT, U/L | ||||
  < 9.0 vs 9.0–50.0 | 5,182,031.57 (0–Inf) | 0.99 |  |  |
 9.0–50.0 vs > 50.0 | 0.64 (0.22–1.87) | 0.42 |  |  |
AST, U/L | ||||
  < 15.0 vs 15.0–40.0 | 0.9 (0.05–16.6) | 0.94 |  |  |
 15.0–40.0 vs > 40.0 | 0.67 (0.23–1.94) | 0.46 |  |  |
GGT, 10.0–60.0 vs > 60.0 | 3.75 (0.29–47.99) | 0.03 | 2.643 (0.04–179.11) | 0.03 |
TBIL, 2–21 vs > 21 µmol/L | 1.05 (0.26–4.32) | 0.94 |  |  |
DBIL, ≤ 5.1 vs > 5.1 | 0.88 (0.32–2.42) | 0.8 |  |  |
ALP, U/L | ||||
  < 45.0 vs 45.0–125.0 | 4 (0.21–75.66) | 0.36 |  |  |
 45.0–125.0 vs > 125.0 | 1.69 (0.29–9.94) | 0.56 |  |  |
CRP, ≤ 0.6 vs > 0.6 mg/dl | 1.08 (0.26–4.46) | 0.91 |  |  |
AFP, ≤ 200 vs > 200 ng/ml | 2.99(1.04–8.57) | 0.04 | 6.268 (1.40–28.09) | 0.02 |
CA199, ≤ 27 vs > 27 U/ml | 0.58 (0.2–1.67) | 0.32 |  |  |
CEA, ≤ 5.0 vs > 5.0 ng/ml | 0.65 (0.18–2.38) | 0.52 |  |  |
HBsAg, positive vs negative | 1.76 (0.57–5.49) | 0.33 |  |  |
HBsAb, Positive vs negative | 1.25 (0.39–4.06) | 0.71 |  |  |
HBeAg, Positive vs negative | 0.87 (0.27–2.85) | 0.82 |  |  |
HBcAb, Positive vs negative | 1.57 (0.41–5.98) | 0.5 |  |  |
Anti-HCV, Positive vs negative | 1.21 (0.23–6.49) | 0.82 |  |  |
Protein score, High vs low | 2.72 (1.69–4.38) | 0.0001 | 14.39 (3.47–59.65) | 0.0001 |